News & Events
Events & Seminars
Harvey Clewell, Ph.D., DABT
Director, Center for Human Health Assessment, The Hamner Institutes for Health Sciences
ACDRS Workshop Series – Frontiers in Drug Development & Regulatory Sciences
The Risk-Benefit-Value Equation:
Physiologically Based Pharmacokinetics (PBPK) in Drug Development and Regulation
Principles of PBPK, Illustrated by Use in Risk and Safety Assessment
Washington, D.C.
Thursday, September 23, 2010
American College of Toxicology - 31st Annual Meeting
Baltimore, MD
November 7-10, 2010
Symposium: Translational Approaches to Drug & Device Safety
Co-chair: Darol Dodd, Ph.D., DABT
Alison Harrill, Ph.D.
The Hamner-UNC Institute for Drug Safety Sciences
Development of New In Vivo Models for Population-Based Risk
Harvey Clewell, Ph.D., DABT
Director, Center for Human Health Assessment, The Hamner Institutes for Health Sciences
Application of Biosimulation Platforms to Safety Testing
Upcoming Seminars at The Hamner
Vicki Seyfert-Margolis, Ph.D.
Senior Advisor, Sciences Innovation and Policy for the FDA Commissioner’s Office
Title pending
Thursday, Aprilr 7, 2011
Recently Held Seminars
Lee Graves, Ph.D.
Department of Pharmacology University of North Carolina, School of Medicine
Title pending
Thursday, December 3, 2009
Shawn Burgess, Ph.D.
Advanced Imaging Research Center and
Department of Pharmacology
Graduate School of Biomedical Sciences University of Texas Southwestern Medical Center
Title pending
Thursday, November 19, 2009
Don Rose, Ph.D.
Vice President, Metabolon Inc.,
Research Triangle Park, NC
The application of metabolomics to drug action and safety
Thursday, November 12, 2009
Alex Tropsha, Ph.D.
Chair, Division of Medicinal Chemistry and Natural Products,
University of North Carolina, School of Pharmacy
Are in vitro data useful for predicting chemical toxicity?
Thursday, October 29, 2009
Daniel Gatti
Postdoc Candidate in Environmental Sciences & Engineering with a Certificate in Bioinformatics and Computational Biology, Gillings School of Global Public Health, UNC at Chapel Hill
Genome-Wide Association Mapping in Inbred Mice
Tuesday, October 20, 2009
2:00 pm
William K. Kaufmann, Ph.D.
Department of Pathology and Laboratory Medicine,
University of North Carolina,
School of Medicine
Systems biology of environmental cancer
Thursday, October 1, 2009
10:00 am
O. Joseph Trask, Jr.
Head of Cellular Imaging Technologies,
Center for Drug Discovery,
Duke University Medical Center,
Durham, NC
High Content Imaging Approaches to Study Neurodegeneration in Primary Cells & Tissue
Monday, August 31, 2009
Les Recio, Ph.D., DABT
Division Director,
Genetic Toxicology,
ILS,
Research Triangle Park, NC
Quantitative Measures of Genotoxicity and Mutagenicity to Examine Dose-Response of Genotoxic Exposures
Wednesday, August 26, 2009
Paul Carmichael, Ph.D.
Science Leader: Prevention of Cancer,
Unilever - Safety and Environmental Assurance Centre
Colworth Science Park,
Sharnbrook, Bedfordshire, UK
Unilever and the Cancer Risk Assessment of Cosmetic
Ingredients - the In Vitro Challenge
Monday, August 10, 2009
Dr. Richard Brennan
Director of Toxicology, GeneGo Inc.
In Silico Differentiation of Reactive Metabolite Generation and Cardiotoxicity Profiles for the Anti-psychotic Drugs Clozapine and Olanzapine
Wednesday, May 13, 2009
Alison Harrill, Ph.D.
Postdoctoral Fellow, The Hamner – UNC Center for Drug Safety Sciences
The Road to Personalized Medicine: Systems Biology Approaches to Understand
and Predict Toxicity
Friday, April 3, 2009
William Wetsel, Ph.D.
Associate Research Professor
Director, Mouse Behavioral and Neuroendocrine Analysis Core Facility
Psychiatry and Behavioral Sciences
Duke University Medical Center, Durham, NC Phenotyping Mice with Attitudes
Friday, April 3, 2009
Lishan Su, Ph.D.
Professor of Microbiology & Immunology, Lineberger Cancer Center, UNC at Chapel Hill
Modeling Therapeutic Applications of Human Stem Cells in Mice: Blood and Liver
Thursday, April 2, 2009
Dr. Tim Wiltshire
Associate Professor, Department of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, UNC at Chapel Hill
Genetic Variation in Mice: Modeling Disease, Pharmacogenetics, and Basic Biology
Wednesday, March 11, 2009
David Moore, Ph.D.
Department of Cell Biology, Baylor College of Medicine, Houston, TX
Lipotropic nuclear receptors - Best for diabetes?
Friday, March 6, 2009
David Threadgill, Ph.D.
Chair, Department of Genetics, North Carolina State University
Epidermal Growth Factor Receptor: An Evolving Story of Gene X Environment Interactions
in Cancer, Obesity and Heart Disease
Friday, February 13, 2009
Kim Brouwer, Pharm.D., Ph.D.
George H. Cocolas Distinguished Professor and Chair,
Pharmacotherapy & Experimental Therapeutics,
UNC Eshelman School of Pharmacy
Hepatic Transporters and Hepatotoxicity
Thursday,
February 5, 2009
Cynthia Sollod, Ph.D.
Manager, Science and Technology Development Program North Carolina Biotechnology Center Funding Opportunities through the North Carolina Biotechnology Center
Tuesday, January 27, 2009
Jefferson Chan M.D., Ph.D.
Associate Professor, Department of Laboratory Medicine and Pathology
University of California Irvine School of Medicine
Molecular and Genetic Analysis of Nrf1 Transcription Factor in Stress Response
Friday, January 16, 2009
Mathew Pletcher, Ph.D.
Senior Principal Scientist, Investigative Toxicology, Pfizer Global Research and Development
Inbred Mouse Genomics: Using a Mouse Model to Better Understand Human Phenotypic Diversity
Thursday, January 15, 2009